Results 1 to 4 of 4 matches
Category 3 - THERAPEUTIC PROCEDURES
15338 - Additional Information
Prostate, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance:
(a) for a patient with:
(i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and
(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and
(iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and
(b) performed by an oncologist at an approved site in association with a urologist; and
(c) being a service associated with:
(i) services to which items 37220 and 55603 apply; and
(ii) a service to which item 60506 or 60509 applies
Fee: $1,029.80 Benefit: 75% = $772.35 85% = $931.10
(See para TN.2.2 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
15513 - Additional Information
RADIATION SOURCE LOCALISATION using a simulator or x-ray machine or CT of a single area, where views in more than 1 plane are required, for brachytherapy treatment planning for I125 seed implantation of localised prostate cancer, in association with item 15338
Fee: $337.40 Benefit: 75% = $253.05 85% = $286.80
(See para TN.2.3 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
15539 - Additional Information
BRACHYTHERAPY PLANNING, computerised radiation dosimetry for I125 seed implantation of localised prostate cancer, in association with item 15338
Fee: $690.45 Benefit: 75% = $517.85 85% = $591.75
(See para TN.2.3 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
37220 - Additional Information
Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance:
(a) for a patient with:
(i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and
(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and
(iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and
(b) performed by a urologist at an approved site in association with a radiation oncologist; and
(c) being a service associated with:
(i) services to which items 15338 and 55603 apply; and
(ii) a service to which item 60506 or 60509 applies
(Anaes.)
Fee: $1,149.35 Benefit: 75% = $862.05
(See para TN.8.55 of explanatory notes to this Category)
Results 1 to 4 of 4 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change